JP2025124904A5 - - Google Patents

Info

Publication number
JP2025124904A5
JP2025124904A5 JP2025097871A JP2025097871A JP2025124904A5 JP 2025124904 A5 JP2025124904 A5 JP 2025124904A5 JP 2025097871 A JP2025097871 A JP 2025097871A JP 2025097871 A JP2025097871 A JP 2025097871A JP 2025124904 A5 JP2025124904 A5 JP 2025124904A5
Authority
JP
Japan
Prior art keywords
seq
acid sequence
nucleic acid
vaccine
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025097871A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025124904A (ja
Filing date
Publication date
Priority claimed from JP2022542413A external-priority patent/JP7696909B2/ja
Application filed filed Critical
Publication of JP2025124904A publication Critical patent/JP2025124904A/ja
Publication of JP2025124904A5 publication Critical patent/JP2025124904A5/ja
Pending legal-status Critical Current

Links

JP2025097871A 2020-01-09 2025-06-11 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 Pending JP2025124904A (ja)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US202062958809P 2020-01-09 2020-01-09
US202062958827P 2020-01-09 2020-01-09
US62/958,827 2020-01-09
US62/958,809 2020-01-09
US202062967104P 2020-01-29 2020-01-29
US202062967242P 2020-01-29 2020-01-29
US62/967,104 2020-01-29
US62/967,242 2020-01-29
US202063064571P 2020-08-12 2020-08-12
US202063064506P 2020-08-12 2020-08-12
US63/064,506 2020-08-12
US63/064,571 2020-08-12
US202063112219P 2020-11-11 2020-11-11
US202063112202P 2020-11-11 2020-11-11
US63/112,202 2020-11-11
US63/112,219 2020-11-11
JP2022542413A JP7696909B2 (ja) 2020-01-09 2021-01-08 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法
PCT/US2021/012630 WO2021142212A1 (en) 2020-01-09 2021-01-08 Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022542413A Division JP7696909B2 (ja) 2020-01-09 2021-01-08 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法

Publications (2)

Publication Number Publication Date
JP2025124904A JP2025124904A (ja) 2025-08-26
JP2025124904A5 true JP2025124904A5 (cg-RX-API-DMAC7.html) 2026-03-06

Family

ID=74505354

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022542413A Active JP7696909B2 (ja) 2020-01-09 2021-01-08 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法
JP2025097871A Pending JP2025124904A (ja) 2020-01-09 2025-06-11 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022542413A Active JP7696909B2 (ja) 2020-01-09 2021-01-08 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法

Country Status (13)

Country Link
US (5) US12605444B2 (cg-RX-API-DMAC7.html)
EP (1) EP4087605A1 (cg-RX-API-DMAC7.html)
JP (2) JP7696909B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220163354A (cg-RX-API-DMAC7.html)
CN (2) CN115335076B (cg-RX-API-DMAC7.html)
AU (1) AU2021205936A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022013620A2 (cg-RX-API-DMAC7.html)
CA (1) CA3166989A1 (cg-RX-API-DMAC7.html)
IL (1) IL294387A (cg-RX-API-DMAC7.html)
MX (1) MX2022008572A (cg-RX-API-DMAC7.html)
PH (1) PH12022551648A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021142212A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202310905B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115335076B (zh) * 2020-01-09 2025-10-28 病毒治疗有限责任公司 编码与疱疹病毒糖蛋白d融合的乙型肝炎病毒抗原的腺病毒载体及其使用方法
WO2026093412A2 (en) * 2024-10-29 2026-05-07 Nec Oncoimmunity As Hbv vaccine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012502A2 (en) 2003-03-28 2005-02-10 Idm Pharma, Inc. Methods of identifying optimal variants of peptide epitopes
US20090246220A1 (en) * 2006-08-28 2009-10-01 Ertl Hildegund C J Constructs for enhancing immune responses
PE20140844A1 (es) 2011-02-12 2014-07-14 Globeimmune Inc Terapeuticos a base de levadura para infeccion de la hepatitis b cronica
GB201223386D0 (en) * 2012-12-24 2013-02-06 Immune Targeting Systems Its Ltd Vaccine
EP2959915A1 (en) * 2014-06-23 2015-12-30 Institut Pasteur A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
CN105367662B (zh) * 2014-08-29 2021-03-12 汤正好 一种hbv相关的融合蛋白、其制备方法及其应用
WO2017176319A1 (en) * 2016-04-06 2017-10-12 University Of Washington Therapeutic vaccine for hepatitis b virus (hbv) using the hbv core antigen
EP3490610A4 (en) 2016-08-01 2020-05-20 The Wistar Institute Of Anatomy And Biology COMPOSITIONS AND METHODS FOR REPLICATION-DEFICIENT ADENOVIRAL VECTORS FOR VACCINE APPLICATIONS
HRP20241379T1 (hr) * 2019-09-30 2024-12-20 Gilead Sciences, Inc. Cjepiva za hbv i postupci za liječenje hbv
CN115335076B (zh) * 2020-01-09 2025-10-28 病毒治疗有限责任公司 编码与疱疹病毒糖蛋白d融合的乙型肝炎病毒抗原的腺病毒载体及其使用方法

Similar Documents

Publication Publication Date Title
CN104884082B (zh) 用作诱导抗原特异性t细胞反应的免疫原性增强剂的融合蛋白
JP2023506765A5 (cg-RX-API-DMAC7.html)
JP2006149406A5 (cg-RX-API-DMAC7.html)
JP2006187292A5 (cg-RX-API-DMAC7.html)
JP2008529558A5 (cg-RX-API-DMAC7.html)
JP2023518596A5 (cg-RX-API-DMAC7.html)
JP2008536483A5 (cg-RX-API-DMAC7.html)
JP2010522540A5 (cg-RX-API-DMAC7.html)
CA2299677A1 (en) Preparation and use of recombinant influenza a virus m2 constructs and vaccines
JP2003530839A5 (cg-RX-API-DMAC7.html)
JP2017513502A5 (cg-RX-API-DMAC7.html)
PL363071A1 (pl) Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
JP2015521467A5 (cg-RX-API-DMAC7.html)
RU2363492C2 (ru) Вакцина
JP2024532503A5 (cg-RX-API-DMAC7.html)
JP2015509707A5 (cg-RX-API-DMAC7.html)
JP2002206000A5 (cg-RX-API-DMAC7.html)
TWI621627B (zh) 用於豬生殖與呼吸綜合症及豬環狀病毒關聯疾病之疫苗組成物
JP2012516140A5 (cg-RX-API-DMAC7.html)
JP2023542297A5 (cg-RX-API-DMAC7.html)
JP2024541465A5 (cg-RX-API-DMAC7.html)
JP2022551813A5 (cg-RX-API-DMAC7.html)
DK1893228T3 (en) CHIMERIC POLYPEPTIDES AND THEIR THERAPEUTIC APPLICATIONS TOWARDS A Flaviviridae INFECTION
JP2023510544A5 (cg-RX-API-DMAC7.html)
JP2015525794A5 (cg-RX-API-DMAC7.html)